The Board of Infinity Pharmaceuticals, Inc. approved the termination, without cause, of the employment of Robert Ilaria, Jr., M.D., as Chief Medical Officer of the Company, effective September 1, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.96% |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
03-25 | Infinity Pharmaceuticals, Inc. Went Out of Business | CI |
1st Jan change | Capi. | |
---|---|---|
-99.96% | 90 | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- INFI.Q Stock
- News Infinity Pharmaceuticals, Inc.
- Infinity Pharmaceuticals, Inc. Announces Resignation of Robert Ilaria, Jr., M.D., as Chief Medical Officer